Working definitions, subjective and objective assessments and experimental paradigms in a study exploring social withdrawal in schizophrenia and Alzheimer&apos;s disease by van der Wee N.J.A. et al.
Contents lists available at ScienceDirect
Neuroscience and Biobehavioral Reviews
journal homepage: www.elsevier.com/locate/neubiorev
Working definitions, subjective and objective assessments and experimental
paradigms in a study exploring social withdrawal in schizophrenia and
Alzheimer’s disease
Nic. J.A. van der Weea,⁎, Amy C. Bilderbeckb, Maria Cabelloc,d, Jose L. Ayuso-Mateosc,d,
Ilja M.J. Sarise, Erik J. Giltaya, Brenda W.J.H. Penninxe, Celso Arangof, Anke Postg,
Stefano Porcellih
a Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands
b P1Vital Ltd, Wallingford, United Kingdom
c Institute of Health Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain
d Department of Psychiatry. Universidad Autonoma de Madrid, Madrid, Spain
e Department of Psychiatry, Amsterdam Neuroscience and Amsterdam Public Health Research Institute, VU University Medical Center and GGZ inGeest, Amsterdam, The
Netherlands
fDepartment of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, CIBERSAM, School of Medicine, Universidad Complutense de Madrid,
Madrid, Spain
g Translational Medicine Neuroscience, Roche, Basel, Switzerland
hDepartment of Biomedical and Neuromotor Science, University of Bologna, Bologna, Italy
A R T I C L E I N F O
Keywords:
Social withdrawal
PRISM
Subjective and objective assessments
Neurobiological and behavioral paradigms in
schizophrenia, Alzheimer and depression
MRI
EEG
Passive remote monitoring
Digital phenotyping
A B S T R A C T
Social withdrawal is one of the first and common signs of early social dysfunction in a number of important
neuropsychiatric disorders, likely because of the enormous amount and complexity of brain processes required to
initiate and maintain social relationships (Adolphs, 2009). The Psychiatric Ratings using Intermediate Stratified
Markers (PRISM) project focusses on the shared and unique neurobiological basis of social withdrawal in
schizophrenia, Alzheimer and depression. In this paper, we discuss the working definition of social withdrawal
for this study and the selection of objective and subjective rating scales to assess social withdrawal chosen or
adapted for this project. We also discuss the MRI and EEG paradigms selected to study the systems and neural
circuitry thought to underlie social functioning and more particularly to be involved in social withdrawal in
humans, such as the social perception and the social affiliation networks. A number of behavioral paradigms
were selected to assess complementary aspects of social cognition. Also, a digital phenotyping method (a
smartphone application) was chosen to obtain real-life data.
1. Background
A recently EU-funded project aims to develop a quantitative biolo-
gical approach to the understanding and classification of neu-
ropsychiatric diseases in order to accelerate the discovery and devel-
opment of better treatments, amongst others via new preclinical animal
models By combining already existing clinical cohort data and by ap-
plying innovative deep-phenotyping technologies to newly recruited
patient groups, the project aims to define a set of quantifiable biological
parameters for social withdrawal and related cognitive deficits in
Schizophrenia, Major Depression, and Alzheimer's disease. Patient
participants, stratified for social withdrawal, will complete a series of
fMRI, EEG, and behavioural paradigms, contribute blood-derived (e.g.
epigenetic) data, and smartphone data related to social behaviour.
Normative data will also be collected from a group of healthy controls.
The project is called Psychiatric Ratings using Intermediate Stratified
Markers (PRISM) (http://prism-project.eu/en/prism-study/). The dif-
ferent papers in this issue of Neuroscience and BioBehavioral Reviews
describe the various aspects of this project, with the first paper detailing
the aims and expectations for the project.
In the present paper, we describe the development of a working
definition of social withdrawal, the selection of appropriate rating
scales, and the selection of experimental and behavioral paradigms for
the assessment and deep phenotyping of social withdrawal for this
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project.
PRISM focuses on social withdrawal, probably one of the first signs
of social dysfunction in a number of important neuropsychiatric dis-
orders, likely because of the enormous amount and complexity of brain
processes required to initiate and maintain social relationships (see
Porcelli et al. in this issue and (Adolphs, 2009). Social withdrawal and
isolation can potentially be observed and measured in an objective way
both in human and in animal models, putatively representing a real-
world indicator of social dysfunction, in contrast to experimental
measures of impairments in social cognition. (Torralva et al., 2013).
In humans, the complexity of social living is enormous and requires
the coordinate functioning of several processes, such as the detection
and processing of social stimuli, mentalising, bond formation and
maintenance, social learning, etc. (Cacioppo et al., 2014; Dunbar, 2009;
Dunbar and Shultz, 2007). Indeed, the human brain shows a marked
specialization for social functioning and it probably evolved specifically
to sustain our complex social interactions (Dunbar and Shultz, 2007).
This specialization comprises, for example in the cognitive domain,
functions such as: 1) emotional processing, 2) social perception and
knowledge, 3) theory of mind (mentalising), and 4) attributional bias
(Fett et al., 2011), which are globally known as "social cognition". The
so-called social brain, i.e. the circuitry and processes underlying these
functions, is sophisticated but also fragile, since difficulties in social
functioning may arise from even small deficits in any one of the in-
volved processes and circuitry.
Beyond the neuropsychiatric disorders primarily associated with
impairments in social functioning, such as Schizophrenia (SZ)
(Addington and Addington, 2008; Green et al., 2015), Autism Spectrum
Disorders, and Hikikomori (Barak and Feng, 2016; Li and Wong, 2015),
deficits in social functioning have also been demonstrated in Alzhei-
mer's Disease (AD) and other dementias (Dickerson, 2015; Havins et al.,
2012), Major Depressive Disorder (MDD) (Bora and Berk, 2016;
Kupferberg et al., 2016), Anxiety disorders (Plana et al., 2014), and
Borderline and Antisocial Personality Disorders (Beeney et al., 2015;
Jeung and Herpertz, 2014; Patin and Hurlemann, 2015a, 2015b). Social
dysfunction represents a common, often severe and deleterious,
symptom of all these disorders, which is likely partially independent
from the other psychopathological core features of the disorders (Bowie
et al., 2008; Dickerson, 2015; Fett et al., 2011; Puig et al., 2008;
Shinagawa et al., 2015).
Taken together, although social functioning as a whole is clearly
influenced by a variety of socio-demographic and environmental fea-
tures, a growing body of evidence suggests that across psychiatric dis-
orders disturbances in social functioning are also related to dis-
turbances at the level the of the social brain (Bickart et al., 2014;
Hampton et al., 2016).
1.1. Working definition of social withdrawal
Social withdrawal is a complex deviation from normal behaviour
and may be defined in several ways, which could be a reason for a lack
of specific investigations of this phenomenon in the past. It is a complex
phenotype, influenced by a variety of socio-demographic features, such
as age, culture, economic status, availability of transports, mobility
impairment, etc., which are hard to completely capture. Moreover,
social network size varies greatly among healthy individuals, ranging
from very small to very large networks (Hill and Dunbar, 2003). Thus,
variability in social behaviour due to socio-demographic and personal
features has to be taken into account in research on disturbances of
social functioning.
Since the current project aims to investigate in a cross-sectional way
the neurobiological basis of social withdrawal manifesting in a set of
specific neuropsychiatric disorders, the researchers decided to focus on
reduced social interaction that had become evident at or after disease
onset and was likely associated with the target disease, and not to other
factors such as pure economical or environmental ones (for details on
the PRISM clinical study, see the paper by Dawson et al. in this issue).
Consequently, the first part of working definition of Social Withdrawal
was: "Reduced social interaction associated with the target dis-
ease".
A problem with the assessment of social functioning when having to
rely on self-report in a cross-sectional design, is the poor insight often
observed in patients with SZ and AD. To address this possible bias, we
decided to add: "as confirmed by the patient and/or significant
other". The term "significant other" is used to specify that this should be
a person who knows the patients' social habits and their changes after
the disease onset, but not necessarily a family member or care taker.
Finally, the difference between objective social withdrawal and
subjective feelings of loneliness had to be taken into account. Feelings
of loneliness can be defined as ‘the distressing feelings that accompany
the perception that one’s social needs are not being met by the quantity
or the quality of the one’s social relationships’ (Hawkley and Cacioppo,
2010). Loneliness and objective social withdrawal might have, at least
partially, different neurobiological substrates (Cacioppo et al., 2015),
thus the concomitant evaluation of both these aspects was thought to
provide more comprehensive information about the social functioning
of subjects (Cacioppo et al., 2014). Therefore, it was decided to include
also an evaluation of the subjective feeling of loneliness.
Since social withdrawal as a specific construct and phenotype has
never been investigated extensively before, one would ideally develop a
specific assessment scale. The development and validation of such a
specific scale, however, would require considerable time and efforts
which was not compatible with the IMI 2 call directives. Instead a
comprehensive literature review was done to identify already available
instruments that could be used to assess (proxies of) social withdrawal.
In particular, two sets of tools have been selected: one for the psycho-
metric assessment of social withdrawal (i.e. scales and questionnaires)
and one for the assessment of key elements of social cognition under
experimental conditions (i.e. MRI, EEG and behavioral paradigms).
Finally, PRISM will try to integrate these assessments with a single
objective measure of social withdrawal, derived from a Smartphone
application developed for this aim (Eskes et al., 2016). The Smartphone
application will also provide an objective measure of telephone and
social media use, which is complementary information to the ones
measured by rating scales and instrumental paradigms.
1.2. Criteria for rating scales and experimental paradigms
In order to select the rating scales and experimental paradigms for
the assessment of social withdrawal in a pragmatic way, given the
specificaims and time constraints of the project, the following set of
criteria was chosen:
1 Robustness and feasibility of implementation
2 Applicability to the population under investigation (i.e. AD, SZ, and
MDD)
3 Allowing the integration of EEG and fMRI analyses
4 Possible alignment with measures used in the already available
clinical cohorts
5 Potential for reverse translation into animal models
More in detail, the arguments for this specific set of criteria were the
following. Choosing instruments which already had demonstrated their
reliability and robustness would avoid bias due to assessment weakness.
Also, due to the time schedule foreseen for a project in the IMI 2 Call,
the selected tools need to be implemented in the clinical recruitment
centres as soon as possible. As the time schedule did not allow a pre-
liminary phase for validation of tools in clinical populations, applic-
ability to the specific clinical samples (i.e. SZ, AD and MDD) was an-
other criterion. Further, we chose in to investigate as much as feasible
both the fMRI and EEG correlates of specific neurocognitive domains
putatively involved in social withdrawal, in order to obtain a
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comprehensive picture of the psychobiological correlates. Since PRISM
has access to several large clinical, but not deep-phenotyped, cohorts
which will be used for preliminary studies of social withdrawal,
alignment with measures used in these cohorts will increase data
comparability. Finally, a key point of the project is the back-transla-
tional intent, i.e. to develop novel preclinical testing paradigms derived
from studies in humans. Therefore, the selected measures should ideally
have characteristics which can be translated in preclinical paradigms.
2. Rating scales selected for PRISM
2.1. Screening scale: WHO disability assessment schedule - domain 4 -
adapted for PRISM
For the cross-sectional clinical study (see paper by Bilderbeck et al.
in this issue) in which newly recruited patients will be deep pheno-
typed, we first had to decide on a screening tool which would allow to
identify within populations currently followed by the clinical centres,
patients with probable low and high levels of social withdrawal who
could be included in this study. After reviewing the literature, we
deemed as most promising scale the WHO Disability Assessment
Schedule (WHODAS) (Ustün et al., 2010), which assesses different do-
mains of functioning, including social functioning. The reasons for this
selection were 1) the WHODAS extensive prior use in both clinical
(including SZ, AD and MDD) and in general populations; 2) the open
access availability of 3) multiple language translations; 4) the time
needed to administer, particularly for a single WHODAS domain (i.e.
2–5minutes); 5) the availability of a self- and a caregiver-report ver-
sion; 6) the already validated possibility to administer only the ques-
tions for a single domain.
Two WHODAS domains appeared particularly suitable for a
screening purpose: the domain 4 ("Getting along ") and the domain 6
("Participation"). WHODAS domain 4 assesses getting along with other
people and difficulties that might be encountered with this due to a
health condition, while WHODAS domain 6 assesses what restrictions
to participate, subjects experience from other people, laws and other
features of their environment.
To verify the suitability and the distribution of these two domains
for PRISM, we performed an exploratory analysis in the already avail-
able cohorts in which the WHODAS was administered. We were able to
perform this analysis for all three disorders, i.e. AD, SZ, and MDD. The
results showed a good distribution of the scores for domains 4 and 6,
suggesting their suitability for screening purposes. However, some
adaptations to the original questions were suggested to increase the
usefulness of these domains for screening. In particular, item 5 of do-
main 4 (i.e. "Sexual activities") was thought to introduce a potential
bias, as PRISM will focus on clinical populations which differ greatly in
age (i.e. AD, SZ, and MDD) and partner status (e.g. SZ patients often
without partner). Therefore, it was decided to not include this item in
the screening tool. Further, among the items of domain 6, the first item
(i.e. "Problems in joining in community activities") was deemed re-
levant for social withdrawal, while the other items assess other con-
sequences of disabilities not relevant for studying social withdrawal
(e.g. financial aspects, emotional impact, laws etc.). So, the final
screening tool included the first four items of WHODAS domain 4 and
the first item of WHODAS domain 6, resulting in an adapted scale of
five items. This adapted scale was tested in subsamples of the already
available cohorts (Netherlands Study Depression and Anxiety (636
healthy controls, 1024 patients with MD) and CIBERSAM (55 patients
with AD, 282 patients with SZ and 102 healthy controls) showing a
good distribution and good discriminatory capacity for high and low
levels of social withdrawal.
2.2. Evaluation of social functioning: social functioning scale (Birchwood
et al., 1990)
Based on the literature review, we selected for the deep phenotyping
clinical study a psychometric instrument providing an assessment of
social withdrawal as well as a more comprehensive assessment of social
functioning: The Social Functioning Scale (SFS). As recently empha-
sized by Green et al., 2017, a better understanding of social disability in
neuropsychiatric disorders, such as schizophrenia, requires to disen-
tangle its constituent components. Importantly, although the SFS was
not specifically designed to exam social withdrawal, the SFS contains
three sections assessing aspects of social withdrawal, i.e. the sections on
1) social withdrawal/engagement, 2) interpersonal behaviour and 3)
pro-social engagement. The main other reasons for the selection of the
SFS were that 1) it has been extensively used, particularly in SZ (e.g.
(Simons et al., 2016)) but also in AD (e.g. (Torralva et al., 2000)) and
MDD (De Silva et al., 2013). 2) Its validity and reliability have been
extensively demonstrated (De Silva et al., 2013). 3) Its administration
time (i.e. 15min) and its self-report and caregiver-report versions made
this scale very suitable for PRISM’s aims and timeline. 4) Normative
data on healthy controls are available, allowing the comparison of
populations differing by age (e.g. SZ and AD populations). 5) The SFS
allows to discriminate patients with social functioning deficits from
those without any impairments in social functioning. 6) It is available
both in Spanish and Dutch (the two languages used in the PRISM
clinical centres). 7) Finally, the SFS provides, next to an assessment of
social withdrawal, a detailed and comprehensive picture of social
functioning, assessing functioning in several areas of social life such as
the marital role, the household role, social/recreational activities, in-
terpersonal relationships, independence/self-care. A main concern with
regard to the SFS with regard to the more comprehensive assessment,
was its section about work activities, since AD patients are usually re-
tired. However, normative data were available for both employed and
unemployed populations, allowing its use also in retired population.
The SFS contains information about the quality of behaviours, but also
objective measures can be extracted, such as social network size. This
may be an important asset, since it potentially permits to better sepa-
rate objective and subjective aspects of social withdrawal, which are
likely sustained by partially different biological substrates (Cacioppo
and Hawkley, 2009).
2.3. Subjective feeling of loneliness and affiliation: the De Jong Gierveld
loneliness and affiliation scale
Although PRISM focuses mainly on objective measures of social
withdrawal, it was decided that feelings of loneliness should also be
taken into account. To this end, we selected the De Jong Gierveld
Loneliness and Affiliation Scale (de Jong-Gierveld, 1987). It measures
the subjective feeling of isolation, explained as the discrepancy between
one’s desired and actual relationships. The main reasons for this choice
were: 1) its validation in clinical and healthy populations; 2) the
availability of normative data for both clinical and healthy populations;
3) its use in several of the already available cohorts ; 4) its self-report
structure; 5) the short time needed for administering (i.e. 5 min); 6) the
detailed assessment of the subjective feeling of perceived isolation.
2.4. Overview of rating scales considered for use in this specific project on
social withdrawal
Apart from the scales that were selected, several other scales were
evaluated during the literature review. The table below summarizes per
evaluated scale the reasons for selecting or not selecting it for use in this
project. Of note, none of the evaluated scales provides an adequate
assessment of internet and social network use. This must be considered
an important limitation, given the increasing importance of this type of
social interactions in today’s societies. However, since the Smartphone
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application included in this project’s protocol (see below) will provide
an objective measure of telephone and social media use, we judged that
this limitation could be partially overcome through data integration
(Table 1)
3. Selection of experimental neurobiological and behavioral
paradigms
Based on several in-depth discussions on the goals, background and
future applicability of potential results from this specific project, the
Table 1
Rating Scale.
Rating Scales Pro Cons Ref.
WHO Disability Assessment Schedule
Domain 4 (Getting along) and 6
(participation)
1. Specifically assesses social interaction
2. Extensive prior use in SZ, AD and MDD
3. Used in already available cohorts in PRISM
4. Administration time of 2-5 minutes
5. Availability of self- and caregiver versions in
Spanish and Dutch
6. Possibility to administer only a single Domain
1. Adaptation needed as some items were not
relevant or could introduce potential bias
(Ustün et al., 2010)
The Social Functioning Scale 1. Comprehensive evaluation of social withdrawal
with focus on objective measures.
2. Used in SZ, AD and MDD
3. Robust, normative data on healthy controls
available
4. Administration time 15minutes
5. Self- and caregiver versions in Spanish and Dutch
(Birchwood
et al.,1990)
De Jong Gierveld Loneliness and Affiliation
Scale
1. Validated in SX, AD, MDD and healthy populations
2. Normative data available for clinical and healthy
populations
3. Used in available PRISM cohorts
4. Self-report structure
5. Administration time 5minutes
(de Jong-Gierveld,
1987)
Social Withdrawal Scale 1. Specifically assesses social withdrawal (in Motor
Neuron Disease)
2. Provides info about objective and subjective
aspects of social withdrawal
1. Mainly used in motor neurons disease, few data
from other populations
2. Too much focus on physical disability
(Rigby et al., 1999)
Social Isolation Index 1. Includes the evaluation of marital status,
frequency of contacts with friend, family, children,
the participation in social activities
1. Validity and robustness are still to be
confirmed
2. There are not studies on AD, SZ, and MDD
(Shankar et al.,
2011)
Social Disconnectedness Scale 1. Developed to assess social disconnectedness
specifically
2. Provides an objective evaluation of social
withdrawal
1. Validity and robustness are still to be
confirmed
2. Mainly used in studies on elderly (reliability in
SZ, AD, and MDD to be confirmed)
(Cornwell and
Waite, 2009)
Social Support Network Inventory 1. Provides an objective evaluation of social network
size
1. Does not assess other aspects of social
withdrawal
(Sarason et al.,
1987)
Duke Social Support and Stress Scale 1. Assesses both objective and subjective aspects of
social functioning
1. Complexity of administration
2. Too much focus on stress related issues
(Parkerson et al.,
1991)
Objective Social Outcome Index 1. Assesses employment, accommodation and living
situation
1. Validity and robustness are still to be
confirmed
2. Provides little information, on social
withdrawal
(Priebe et al., 2008)
Lubben Social Network Scale - Revised 1. Provides an objective evaluation of social network
size
2. Widely used in AD, SZ, and MDD
3. Assesses also some subjective aspects of social
withdrawal
1. Provides too limited information for deep
phenotype purposes
2. Assesses mainly the quantity/quality of family
and friend relationships, not taking into account
other aspects of social behaviors
(Lubben et al.,
2006)
Multidimensional Observation Scale for
Elderly Subjects
1. Provides a measure of psychosocial functioning,
covering five domains, including withdrawal
2. Used in a variety of descriptive studies
3. Does not require the cooperation of the person
rated
1. Was developed for diverse purposes in the
elderly, in residential care;
2. Should be substantially modified for PRISM
(Helmes et al.,
1987)
Assessment of subjective feelings associated with Social Withdrawal
Perceived Isolation Scale 1. Developed to specifically assess perceived social
isolation
2. Provides an objective evaluation of social
withdrawal
1. Validity and robustness are still to be
confirmed
2. Mainly used in elderly so far
3. Problems with the reliability in SZ, AD, and
MDD
(Hughes et al.,
2004)
UCLA loneliness scale 1. Extensively used, also in AD, SZ, and MDD
2. Normative data are available
3. Easy to be administered (> short versions)
1. Too much oriented toward concerns of the
young (scale was originally developed for college
students)
(Russell, 1996)
The Social Support Questionnaire 1. Quite extensively used, although it was developed
to assess social support in the general population
1. There are likely differences between sexes
2. Short version may lack reliability
3. Focuses only on perceived social support and
does not assess feeling of loneliness
(Sarason et al.,
1987)
The Multidimensional Scale of Perceived
Social Support
1. Quite extensively used
2. Assesses social support from family, friends and
significant others
3. Easy to administer
1. Focuses only on perceived social support
perceived and does not assess feelings of
loneliness
(Zimet et al., 1990
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choice of experimental paradigms to examine social withdrawal in
PRISM was limited to structural and functional MRI measures, EEG
measures and additional behavioral paradigms. Furthermore, we had to
prioritize because of constraints with regards to the participants burden
and the time path. Within the context of this specific project, general
criteria for paradigm selection for the deep phenotyping were specifi-
city, robustness, feasibility, prior use across SZ and AD patients (and
preferably also MDD), applicability in cross-methodological tasks
(functional MRI, EEG, behavioral) and the availability of (potential)
rodent homologues designed to meet a wider, reverse and forward
translational objective of the project. Finally, the selected paradigms
should probe the systems and neural circuitry thought to underlie social
functioning and more particularly to be involved in social withdrawal
in humans (see review by Porcelli et al in this issue)
3.1. Structural MRI, resting state and task related MRI and EEG paradigms
MRI examinations in the current project comprise both structural
and functional scan sequences. For the structural MRI part, we chose to
acquire routine 3D structuralT1 weighed scans to allow the investiga-
tion of volumetric and shape correlates of measures of social with-
drawal. We additionally chose to acquire Diffusion Tensor Imaging
(DTI) scans to examine parameters of structural connectivity.
Resting state and task related functional MRI (fMRI) and EEG cover
partially different spatial and temporal domains and may in this way be
considered complementary in assessing neural circuitry at rest and
during task related activation.
3.2. Probing the social perception network
3.2.1. Facial emotion processing paradigms
Our literature review of available MRI and EEG paradigms focused
on, but was not limited to studies in patients with SZ, patients with
early AD and to a lesser degree patient with MDD. An obvious candidate
for both a fMRI and a EEG paradigm was a Facial Emotion Processing
(FEP) Task. In this task with a duration of about 10min, subjects ty-
pically are presented faces with different emotional valence, usually
neutral, sad, angry and happy, but other expressions like disgust might
be added.
The FEP was considered as an obvious candidate because of the
importance of the processing of facial expressions in social interaction,
and because of the wide use of the FEP in fMRI and EEG studies across
disorders, as described below. With the FEP task it would be possible to
probe the brain’s Social Perception network and to some extent also the
Aversion network (with more negatively valenced pictures) (see
Porcelli et al in this issue).
Impairments in processing of facial emotions and their association
with social and functional outcome, have been explored in several
studies of SZ patients (Edwards et al., 2001; Marwick and Hall, 2008;
Pinkham et al., 2011). Overall, individuals with SZ show an impairment
in facial emotion recognition compared with healthy controls (Marwick
and Hall, 2008), but this deficit appears to be more pronounced in the
case of negatively-valenced emotional expressions such as fear and
sadness (Edwards et al., 2001). Since the amygdala-based Perception
Network is thought to play an important role in the processing of ne-
gative emotions such as fear (Adolphs, 2002), these findings are con-
sistent with the reduced amygdala volume (Wright et al., 2000) and
amygdala hypoactivation observed in SZ patients, especially when
comparing BOLD signal changes elicited by fearful versus neutral faces
(Aleman and Kahn, 2005). Of special relevance to the current project,
Bark et al. found in a recent review and meta-analysis that facial
emotion identification was already impaired in patients with early-
onset and first-episode psychosis (Barkl et al., 2014), with a generalized
effect of poorer accuracy of identifying expressions.
Results from EEG studes using a FEP paradigm corroborate with the
observation that processing of emotional facial expressions is aberrant
in SZ. The N170 evoked response potential (ERP), thought to be face-
sensitive, is generally observed to be of reduced amplitude in response
to facial stimuli in SZ (Tsunoda et al., 2012; Turetsky et al., 2007).
Altered theta power and N170 ERPs following presentation of emo-
tional faces may signal difficulties in the integration of socio-emotional
processing and sustained attention in SZ (Brenner et al., 2016). In a
recent meta-analysis of face processing ERPs in SX, the amplitude of
both the N170 ERP and the N250 ERP in response to facial stimuli was
smaller in patients, with comparable effect sizes (McCleery et al.,
2015). Notwithstanding the results of this meta-analysis, there is het-
erogeneity in research findings from individual studies, some of which
may be accounted for by variability in social withdrawal between SZ
patients. For example, a study by Pinkham et al. (2011) found no sig-
nificant differences between overall performance on a facial emotion
processing (FEP) task between SZ and control participants, but a spe-
cific tendency in the SZ group to misattribute anger to neutral faces.
Their sample of SZ patients were experiencing prominent paranoid
symptoms, which itself is likely to be linked to increased social with-
drawal. Thus, it is possible that different levels of social withdrawal are
associated with different information processing patterns and biases in
SZ patients, and that the FEP task is sensitive to those differences.
Supporting this idea, N170 ERPs have been linked to social functioning
in patients with SZ (McCleery et al., 2015). Furthermore, a study
combining three measures of emotion recognition (Facial Emotion
Identification Test, Voice Emotion Identification Test and Videotape
Affect Perception Test) found that the total score on these measures at
baseline predicted improvement in functional outcomes following a 12-
month community-based psychosocial rehabilitation for patient with SZ
(Brekke et al., 2007). Difficulty in facial affect processing and especially
recognition has also been documented in relation to AD and MCI. For
instance, compared to healthy elderly controls, elderly individuals with
MCI tend to perform significantly worse on FEP tasks, regardless of the
affective valence of the facial expression, but with better performance
when intensity is increased (Sarabia-Cobo et al., 2015). A more pro-
nounced deficit was suggested, however, in terms of recognising dis-
gust. Of interest, several studies report a recognition impairments in
patients with early-stage Alzheimer’s disease (Hot et al., 2013; Sapey-
Triomphe et al., 2015)
In conclusion, impairments related to facial emotion identification
and processing are evident in both SZ and AD patients. However, as
conceptualised in the RDOC approach, diagnostic groups may differ
both behaviorally and by neural substrates across the processing of
emotional facial expressions or valence. The specific profiles of deficits
are likely to have a relationship with social behaviour, and in particular
social withdrawal.
A relative wealth of previous data exists to compare our findings
with, although no previous study has directly compared findings from
SZ and AD patients. The FEP tasks were well-tolerated in these patient
groups, and indeed these pardigms are of relatively short duration
(10–15min). By collecting both fMRI and EEG data during FEP we will
gather data with these methodologies’ higher spatial and temporal re-
solution, respectively, allowing a more comprehensive understanding
of implicated neural processes. Of relevance for the potential later
stages of the current project, an extensive body of literature also
documents abnormalities in the processing of facial emotional expres-
sions in patients with MDD as examined with fMRI and EEG, also in
remitted and early stages of the disease (Delle-Vigne et al., 2014;
Groenewold et al., 2013; Cusi et al., 2013). A relative disadvantage of
the use of FEP paradigms in the current project may be the lack of
comparable robust paradigms in animals other than non-human pri-
mates, especially rodents, limiting reverse and forward translation.
3.2.2. Affective prosody
The working group also considered paradigms focused on the de-
tection of affective prosody (i.e. the emotional modulation of voices) as
potential tools to probe the social perception network. Deficits in
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auditory emotion recognition have been demonstrated in patients with
SX and impairments were shown to be related to levels of social func-
tioning (Hoertnagl CM et al. 2014). Some studies have also shown al-
tered processing of affective prosody in patients with AD (Lee et al.,
2014). However, given that this paradigm overlaps with the FEP in
probing the social perception network, and that for the FEP paradigm a
lager body of data existed and ample experience was available in the
PRISM consortium, preference was given to the FEP.
3.3. Probing the social affiliation network
3.3.1. Monetary and social incentive delayed task
There was a discussion in the working group, also inspired by
comments from the projects reviewers’ panel, that within the social
cognition domain one should next to the basic processing of the so-
cially-relevant stimuli (such as facial expression) also consider the re-
warding or punishing properties of these social stimuli as assessed by
elements of the brain’s Social Affiliation system. Reduced or altered
reward processing associated with social stimuli is likely to be asso-
ciated with reduced motivation or capacity to interact socially (Gossen
et al., 2014).
The working group identified a number of paradigms focused on the
processing of monetary like reward, but also a relatively novel task
combining this with probing the processing of social incentives. This
Monetary and Social Incentive Delayed task (MSID) allows collection of
neural data relevant to the processing of both non-social (monetary)
and social (facial expression) rewards. The MSID is based on the
Monetary Incentive Delay Task (MID), a well-replicated and validated
paradigm that measures both the receipt of rewards as well as reward
anticipation, and which robustly activates areas of the brain associated
with reward processing including the ventral striatum (Knutson et al.,
2001; Rademacher et al., 2014). Using this task, it has been shown that
in SZ reward anticipation is directly impaired and associated with re-
duced activation of the ventral striatum: impaired reward anticipation
has been observed in both unmedicated patients with SZ and those
treated with typical antipsychotics (Kirsch et al., 2007; Schlagenhauf
et al., 2008). A negative correlation has also been found between
ventral striatum activation and overall level of negative symptoms,
suggesting that it may be a biomarker of negative symptoms in SZ
(Juckel et al., 2006; Waltz et al., 2007). The MID is therefore a bio-
marker model for reward anticipation that is independent of learning,
and is thought to be sensitive to negative symptomatology in SZ.
The MSID is an extension of the MID, including blocks of trials that
examine both monetary as well as social reward, with a total duration
of around 20min. Social rewards can, for example, be comprised of
pictures showing happy facial expressions (signalling social cohesion,
shared enjoyment, and/or social approval) at different levels of reward
(i.e. faces at different intensities of happy/smiling expressions). Studies
show that both monetary and social rewards activate the ventral
striatum in healthy controls (Rademacher et al., 2010; Spreckelmeyer
et al., 2009).
Of note, a behavioral-only version of the MSID has been recently
used to explore reward and loss processing in AD and frontotemporal
dementia, although healthy control data was not collected (Perry et al.,
2015). The MSID therefore provides a measure of both reward pro-
cessing more broadly – as may be relevant to symptoms of general
apathy and anhedonia experienced by patients with SZ, AD and MDD –
as well as allowing a direct comparison between reward processing
associated with monetary vs. social rewards. In addition, EEG, beha-
vioral and rodent homologues are available to support future transla-
tional studies. As such, the MSID task was viewed as relevant and va-
luable in achieving PRISM’s goals.
3.3.2. Approach-avoidance paradigms
The workgroup also discussed the potential of a novel elegant ap-
proach-avoidance paradigm to probe the brain’s social affiliation and
social aversion networks. In this paradigm subjects have to move a
joystick towards or away from a stimulus with a specific valence. The
paradigm has been used in some ERP and fMRI studies in healthy
controls (Roelofs et al., 2007, 2009). The paradigm has also been used
in a fMRI study examining the rewarding properties of social interac-
tions in relation to approach motivation traits (Radke et al. 2016). So
far, however, this approach-avoidance paradigm has not been used in
combination with fMRI in patient populations and comparable para-
digms in animals do not exist yet
3.4. Probing the mentalising and mirror networks
Problems in more complex social functioning, involving aspects like
Theory of Mind (ToM) or empathy, have been demonstrated in both SX
and early AD. A review by Sandoz et al. (2014) showed a decrease in
ToM performance in patients with AD, more pronounced in more
complex task. Healey et al. (2016) reviewed the literature on amongst
others ToM performance in patients with first-episode psychosis and
concluded that these patients consistently show a reduced performance.
We therefore reviewed several paradigms developed to study (as-
pects of) more complex social functioning, putatively relying on the
mentalising or mirror network. A variety of these paradigms is avail-
able, but frequently used to study disorders like autism spectrum dis-
orders and sociopathy. More importantly, we considered the fact that
ToM and similar paradigms typically rely on intact executive functions
and may therefore sensitive to the influence of reduced cognitive
abilities as an important limitation for use in the current project
(Sandoz et al., 2014). Furthermore, the potential for more direct reverse
translation of these constructs to animal models, especially in rodents,
is limited. We therefore decided at this stage, also based on the earlier
mentioned restraints for PRISM, not to include a ToM paradigm in our
set of fMRI and EEG paradigms, but to examine this construct in a
behavioral paradigm.
3.5. Behavioral paradigms assessing complementary aspects of social
cognition
The selection of additional behavioral tasks was predominantly
secondary to the selection of imaging and EEG tasks described above.
Behavioral tasks were selected according to the same criteria as ima-
ging and EEG tasks (e.g. sensitivity, feasibility, applicability to patient
with SZ and AD, and potentially MD, and potential for reverse trans-
lation into animal models), but with an emphasis on selection of tasks
that tested aspects of relatively independent, or complementary, do-
mains to those measured during neuroimaging or EEG. In addition,
these tasks could be of a more exploratory nature.
In total six behavioral tests were selected for the study protocol, of
which four tasks to examine additional aspects of social cognition, two
other task examined aspect of other cognitive domains such as atten-
tion. The four additional social cognition tasks were: a task of Facial
Expression Recognition (FERT), two effort-based decision-making tasks
(Deck Choice Effort Task, DCET, and Effort Expenditure for Rewards
Task, EEfRT) to examine motivational aspects and complement the
MSID, and a vignette “Hinting” task probing higher level cognition.
3.5.1. Facial expression recognition task
As a homologue and extension of FEP fMRI and EEG paradigms
probing the social perception network, we selected the Facial
Expression Recognition Task (FERT). It requires participants to view
photos of faces with various expressions, presented very briefly (typi-
cally around 0.5 s), followed by indicating whether the expression was
happy, sad, fearful, disgusted, surprised, angry, or neutral. Faces vary in
the ‘intensity’ of the presented emotion, allowing more detailed ex-
ploration of sensitivity to different facial expressions, as well as bias in
processing (i.e. systematic errors in expression classification). The FERT
and similar tasks have been used widely as a measure of socially-
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relevant emotional information processing across disorders including
SZ, AD and major depressive disorder (MDD). Both SZ and AD groups
seem to be impaired on this task. In SZ, it appears that recognition of
fear (Okada et al., 2015) and sadness (Huang et al., 2011) is more
impaired than the recognition of positive facial expressions of emotion,
and that this impairment is related to the severity of patients’ negative
symptoms (Turetsky et al., 2007). In AD, research suggests that all fa-
cial expressions emotions are affected to the same degree, and im-
pairments in recognition are shown when the emotions presented are
relatively subtle (Torres et al., 2015). Nevertheless, impairments in
facial expression recognition seem to be more noticeable in other forms
of dementia (e.g. frontotemporal dementia (FTD); indeed FERT tasks
are often used in research to differentiate between AD and FTD patients
(Goodkind et al., 2015). The task therefore shows potential both as a
tool for diagnostic differentiation, and in providing behavioral markers
related to symptoms.
The 10min FERT task is easy to implement and the inclusion of a
behavioral version of an emotional face processing task in addition to
the fMRI and EEG version will allow for measurement of responses to a
broader range of facial expressions, as imaging protocols typically only
include four emotional expressions (happy, fearful, sad and neutral),
and at a range of emotional intensities, allowing for more in-depth
analysis of sensitivity curves that are characteristically associated with
emotional expression recognition.
3.5.2. Effort-based decision making paradigms examining motivation
As described in the section on MRI and EEG paradigms, the MSID
task probes neural circuitry putatively involved in sensitivity to (social)
reward and anticipation of (social) reward. A further important aspect
of reward processing is the evaluation of the “cost” of the effort in-
volved in pursuing rewards, i.e. motivation. In SZ and early AD, this
effort-cost computation may be altered in general or in the case of social
reward. Effort-based decision-making tasks aim to assess the degree to
which costs and benefits are incorporated into choice behaviour. These
tasks measure how willing participants are to engage in effortful re-
sponding as a function of the probability and magnitude of potential
rewards or monetary compensation. Healthy participants typically
exert more effort when the probability of a reward is high and mono-
tonically increasing with the value of that reward. Moreover, anhedonia
has been found to correlate with increased effort-cost computations in
healthy volunteers. The willingness to expend effort for low probability
outcomes has been directly related to differences in striatal dopamine
activity (Treadway et al., 2012). In SZ, negative symptoms were found
to relate to reduced willingness to invest effort for larger rewards (Gold
et al., 2013). This suggests a possible role for impaired effort-cost
computations in SZ that are related to negative symptom severity and
may impact on social interaction. We selected for inclusion in the
protocol two short tasks (15min each) for effortful decision-making:
the Deck Choice Effort Task (DCET) and the Effort Expenditure for
Rewards Task (EEfRT). Both these tasks require participants to make a
series of choices between an easier or a more difficult task, for different
levels of reward, but the kind of effort required differs between tasks.
The DCET provides a measure of willingness to expend cognitive effort
for reward, whilst the EEfRT measures willingness to expend motor/
physical effort. Expending effort within these different domains is likely
to involve or recruit partially different brain networks, with cognitive
effort associated more with prefrontal cortex activity, and motor/phy-
sical effort more linked with motor and premotor cortex function. Both
tasks show good external validity (with performance related to negative
symptoms in SZ) and psychometric properties in SZ populations (Horan
et al., 2015; Reddy et al., 2015). Less is known about the validity of the
task in AD patients. However, it is noteworthy that apathy, one of the
most common psychological symptoms of dementia - if not the most
common (Craig et al., 2005; Guimaraes et al., 2008; Landes et al., 2001;
Lyketsos et al., 2002; Onyike et al., 2007) - is likely to be related to
motivational deficits that are detectable in effort-based decision-
making tasks. Furthermore, tasks of comparable cognitive demand in-
volving computations of reward and risk have been used in AD (Sinz
et al., 2008), suggesting that the paradigm is feasible in this patient
group.
3.5.3. The hinting task
The working group decided not to include a MRI or EEG paradigm
probing higher-level social functioning because of the possible con-
found by cognitive impairments, but to examine this more exploratory
in a behavioral paradigm. We selected the Hinting task as a strong
candidate measure of higher-level social cognition (e.g. ToM), to
complement other tasks of lower-level social cognition (such as facial
emotion processing and tasks of simple social reward processing). The
Hinting task has a duration of 10min and measures the ability to infer
the true intent of indirect speech. Participants are read 10 short pas-
sages presenting an interaction between two characters, and each
passage ends with one of the characters dropping a hint. Participants
are then asked what the character truly meant. Participants can earn
partial credit for that passage if they require additional hints. The task
shows notably good psychometric properties, particularly in SZ
(Pinkham et al., 2016). Although vignette tasks such as the Hinting
Task may be viewed as problematic for use in groups with more pro-
nounced cognitive impairments, such as the AD group in the current
study, challenging theory-of-mind tasks have previously been used
successfully in AD (Rowse et al., 2013).
4. Social withdrawal: passive remote monitoring
Clearly, a key challenge in studying a construct like social with-
drawal is to obtain objective measures of social interaction over time
and not to solely having to rely on subjective measures derived from
self-reporting, especially in disorders were self-monitoring may be
compromised, or on the reporting by the significant others of patients.
For the current project, we have therefore chosen to use a smart-
phone application (BeHapp) that has been developed to provide a re-
mote, unobtrusive and objective measure of sociability and social ex-
ploration in a longitudinal daily-life manner using different data
modalities collected through an Android based smartphone (www.
Behapp.com) (Eskes et al., 2016a,b). Once installed, the application
continuously monitors communication and exploration patterns in
participants as a function of social acts (e.g. number of text messages
sent and received, number and duration of phone calls), environment
social density measurements (e.g. blue tooth devices and WiFi in direct
vicinity), GPS location updates and general smartphone usage. The
BeHapp is currently used in ongoing studies in patients with SX, in at-
risk populations and in a large longitudinal study in youth.
A key goal of using BeHapp in the current project is to develop and
validate an objective measure of social withdrawal/sociability, with the
future goal of harmonizing objective and subjective social withdrawal
measures across cohorts and diseases, to allow more focused and ef-
fective research into this construct and its clinical relevance. Of re-
levance, gathering objective patters of social interaction over time in
humans will be also important for back-translation of findings to animal
experimental settings were elaborate methods for objectively tracking
and characterizing social interactions already exist.
Installation of the BeHapp app and submission of the associated
data is optional. When participants do not have an Android smart-
phone, one can be provided by the research team for the duration of the
study. Where participants agree to providing data through BeHapp, the
app will be activated with a unique “key” on each participant’s phone,
and this key will expire after six weeks, so that data collection stops
automatically. Participants will be given instructions and guidance on
how to uninstall the app if it has been installed on a personal phone,
and on how to return the device to the research team if it has been
provided for the duration of the study
No directly identifiable information about any participant is stored
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within any system that is part of the BeHapp service. Also, BeHapp
monitoring data is encrypted before being stored locally on the parti-
cipant’s device and cleared after each successful upload to the secured
server. Furthermore, in no instance any information with regard to the
content of any spoken or written messages is recorded through BeHapp.
In addition, BeHapp irretrievably obfuscates any information related to
any individual interacting with the participant before sending it to the
research database.
In this manuscript, we discussed the working definition of social
withdrawal and the selection of rating scales and experimental and
complementing behavioral paradigms, including a digital phenotyping
approach, for a project investigating the psychoneurobiology of social
withdrawal across three neuropsychiatric disorders. Clearly, although
this project will employ a fairly comprehensive set of assessments, it
should be taken into account that choices were limited by the specific
time constraints and requirements, as well as by the availability and
reliability of currently available instruments and paradigms.
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